Last 3 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Baird Medical Investment Holdings Limited's quarterly P/E stands at 5.0x.
| Metric | TTM | Q4 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|
| P/E Ratio → | 3.57 | 5.00 | — | 32.83 |
| — | — | — | — | |
| P/S Ratio | 1.74 | 1.74 | 1.57 | 1.48 |
| — | — | — | — | |
| P/B Ratio | 1.13 | 4.18 | 2.10 | 1.90 |
| — | — | — | — | |
| P/FCF | — | — | — | — |
| — | — | — | — | |
| EV / EBITDA | 4.88 | 4.27 | 4.25 | 5.06 |
| — | — | — | — | |
| EV / EBIT | 5.37 | 4.50 | 4.74 | 5.76 |
| — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Baird Medical Investment Holdings Limited's operating margin was 42.8% in Q4 2024, up 4.0 pp QoQ. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency.
| Metric | TTM | Q4 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|
| Gross Margin | 88.2% | 88.5% | 87.5% | 82.3% |
| — | — | — | — | |
| Operating Margin | 41.4% | 42.8% | 38.7% | 25.9% |
| — | — | — | — | |
| Net Margin | 33.6% | 34.0% | 33.0% | 20.2% |
| — | — | — | — |
| Metric | TTM | Q4 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|
| ROE | 33.0% | 20.6% | 11.5% | 6.5% |
| — | — | — | — | |
| ROA | 18.5% | 11.5% | 7.6% | 4.5% |
| — | — | — | — | |
| ROIC | 22.6% | 13.8% | 8.5% | 6.1% |
| — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Baird Medical Investment Holdings Limited's Debt/EBITDA ratio is 1.9x, down from 2.7x last quarter — comfortably within a safe range. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '24 | Q2 '24 | Q2 '23 |
|---|---|---|---|---|
| Debt / Equity | 0.53 | 0.53 | 0.40 | 0.02 |
| — | — | — | — | |
| Debt / EBITDA | 1.24 | 1.94 | 2.73 | 0.24 |
| — | — | — | — | |
| Current Ratio | 1.77 | 1.77 | 2.10 | 0.06 |
| — | — | — | — | |
| Quick Ratio | 1.74 | 1.74 | 2.05 | 0.06 |
| — | — | — | — | |
| Interest Coverage | 26.55 | 30.28 | 21.32 | 36.33 |
| — | — | — | — |
Includes 30+ ratios · 3 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying BDMD stock.
Baird Medical Investment Holdings Limited's current P/E is 3.6x. The average P/E over the last 2 quarters is 18.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Baird Medical Investment Holdings Limited's current operating margin is 41.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Baird Medical Investment Holdings Limited's business trajectory between earnings reports.